Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Curdin Conrad

Showing results (81-90 of 117) with videos related to

Pageof 12
Sort By:
Journal of Comparative Effectiveness Research|February 28, 2023
A plain language summary of what freedom from disease means to people with psoriasis according to doctors, nurses, and people with psoriasisIlse van Ee, Elfie Deprez, Alexander Egeberg, et al.
Science Translational Medicine|March 11, 2011
Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosusRoberto Lande, Dipyaman Ganguly, Valeria Facchinetti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 24, 2024
ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasisSara E Cerminara, Ivana Cvijetic, Stephanie Huber, et al.
Journal of the American Academy of Dermatology|March 25, 2026
Impact of early treatment of psoriasis on disease recurrence - Results from the STEPIn studyLars Iversen, Richard G Langley, Johann E Gudjonsson, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
Dermatology and Therapy|April 2, 2026
Retention, Effectiveness, and Safety of Secukinumab in Plaque Psoriasis: 5-Year Results from SERENAMatthias Augustin, Paul-Gunther Sator, Ralph von Kiedrowski, et al.
Nature Medicine|January 18, 2005
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune diseaseKarl S Lang, Mike Recher, Tobias Junt, et al.
Dermatology (Basel, Switzerland)|January 6, 2021
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment PathwayJulia-Tatjana Maul, Florian Anzengruber, Curdin Conrad, et al.
Nature Communications|March 12, 2015
Corrigendum: the antimicrobial peptide LL37 is a T-cell autoantigen in psoriasisRoberto Lande, Elisabetta Botti, Camilla Jandus, et al.
Nature|January 19, 2022
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19Jeremy Di Domizio, Muhammet F Gulen, Fanny Saidoune, et al.
Pageof 12

Showing results (81-90 of 117) with videos related to

Sort By:
Pageof 12
Journal of Comparative Effectiveness Research|February 28, 2023
A plain language summary of what freedom from disease means to people with psoriasis according to doctors, nurses, and people with psoriasisIlse van Ee, Elfie Deprez, Alexander Egeberg, et al.
Science Translational Medicine|March 11, 2011
Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosusRoberto Lande, Dipyaman Ganguly, Valeria Facchinetti, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 24, 2024
ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasisSara E Cerminara, Ivana Cvijetic, Stephanie Huber, et al.
Journal of the American Academy of Dermatology|March 25, 2026
Impact of early treatment of psoriasis on disease recurrence - Results from the STEPIn studyLars Iversen, Richard G Langley, Johann E Gudjonsson, et al.
Dermatology (Basel, Switzerland)|January 10, 2015
The dermatologists' role in managing psoriatic arthritis: results of a Swiss Delphi exercise intended to improve collaboration with rheumatologistsWolf-Henning Boehncke, Mark David Anliker, Curdin Conrad, et al.
Dermatology and Therapy|April 2, 2026
Retention, Effectiveness, and Safety of Secukinumab in Plaque Psoriasis: 5-Year Results from SERENAMatthias Augustin, Paul-Gunther Sator, Ralph von Kiedrowski, et al.
Nature Medicine|January 18, 2005
Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune diseaseKarl S Lang, Mike Recher, Tobias Junt, et al.
Dermatology (Basel, Switzerland)|January 6, 2021
Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment PathwayJulia-Tatjana Maul, Florian Anzengruber, Curdin Conrad, et al.
Nature Communications|March 12, 2015
Corrigendum: the antimicrobial peptide LL37 is a T-cell autoantigen in psoriasisRoberto Lande, Elisabetta Botti, Camilla Jandus, et al.
Nature|January 19, 2022
The cGAS-STING pathway drives type I IFN immunopathology in COVID-19Jeremy Di Domizio, Muhammet F Gulen, Fanny Saidoune, et al.
Pageof 12